NCT07448090Recruiting
Real-World Case Registry Study on Obesity
Source: ClinicalTrials.gov · Last updated 12 Jun 2026
Brief summary (registry, in English)
Obesity is a major risk factor for cardiovascular disease, diabetes, cancer, and other chronic conditions. Due to its complex etiology and frequent comorbidities, effective obesity management requires comprehensive and individualized approaches. This study is a multicenter, prospective, real-world registry designed to evaluate integrated traditional Chinese medicine (TCM) and Western medicine interventions for obesity. The study will enroll at least 10,000 individuals with obesity from urban and rural populations. Multimodal data, including electronic medical records, laboratory test results, imaging data, and lifestyle information, will be collected. The effectiveness of integrated TCM and Western medicine interventions will be assessed across different age groups, disease stages, and obesity-related constitution types. In addition, disease progression patterns and key prevention and treatment points will be explored. Health economic analyses will be conducted to evaluate the cost-effectiveness of different obesity management strategies, providing real-world evidence to support public health policy and the optimization of integrated obesity prevention and management approaches.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 26 Feb 2026
- Start date
- Aug 2024
- Primary completion date
- Jul 2028
- Lead sponsor
- Hubei Hospital of Traditional Chinese Medicine
- Diseases
- Obesity
- NCT number
- NCT07448090
What you commit to
- Study type: Observational
- Planned participants: 10000
- From Aug 2024 to the primary completion date, Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Co-existing severe diseases of the heart, liver, lungs, kidneys, brain, blood, neuro-psychiatric system, or other vital organs.
- Secondary obesity (obesity attributable to another clearly diagnosed disorder, e.g., hypothalamic or pituitary inflammation, tumours or trauma, Cushing's syndrome, hypothyroidism, hypogonadism, polycystic ovary syndrome, etc.).
- Iatrogenic obesity (obesity resulting from drugs or therapeutic interventions administered for other conditions).
Other
- Pregnant or lactating women.
- Subjects whom the investigator deems unsuitable for participation in this study.
Who the study is looking for
- Age 18 years and above, gender not restricted;
- Weight fluctuation within the last 3 months is ≤ 5% and BMI is ≥ 28.0 kg/m2;
- Good compliance, willing to follow the follow-up principles;
- Agree to sign the informed consent form.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hubei Provincial Hospital of Traditional Chinese Medicine Coordinator of this site? Confirm its status | Wuhan | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.